Abstract
Many biomedically relevant biomarkers are proteins with characteristic biochemical properties and a relatively restricted subcellular distribution. The comparative and mass spectrometry-based proteomic analysis of body fluids can be particularly instrumental for the targeted identification of novel protein biomarkers with pathological relevance. In this respect, new research efforts in biomarker discovery focus on the systematic mapping of the human saliva proteome, as well as the pathobiochemical identification of disease-related modifications or concentration changes in specific saliva proteins. As a product of exocrine secretion, saliva can be considered an ideal source for the biochemical identification of new disease indicators. Importantly, saliva represents a body fluid that is continuously available for diagnostic and prognostic assessments. This chapter gives an overview of saliva proteomics, including a discussion of the usefulness of both liquid chromatography and two-dimensional gel electrophoresis for efficient protein separation in saliva proteomics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Aronson JK, Ferner RE (2017) Biomarkers – a general review. Curr Protoc Pharmacol 76:9.23.1–9.23.17
Wiktorowicz JE, Soman KV (2016) Discovery of candidate biomarkers. Adv Exp Med Biol 919:443–462
Zhao Y, Brasier AR (2016) Qualification and verification of protein biomarker candidates. Adv Exp Med Biol 919:493–514
Carr DF, Pirmohamed M (2018) Biomarkers of adverse drug reactions. Exp Biol Med (Maywood) 243:291–299
Hendrikse NM, Llinares Garcia J, Vetter T, Humphreys AJ, Ehmann F (2022) Biomarkers in medicines development-from discovery to regulatory qualification and beyond. Front Med (Lausanne) 9:878942
Dayon L, Cominetti O, Affolter M (2022) Proteomics of human biological fluids for biomarker discoveries: technical advances and recent applications. Expert Rev Proteomics 5:1–21
Gerner C, Costigliola V, Golubnitschaja O (2020) Multiomic patterns in body fluids: technological challenge with a great potential to implement the advanced paradigm of 3P medicine. Mass Spectrom Rev 39:442–451
Csősz É, Kalló G, Márkus B, Deák E, Csutak A, Tőzsér J (2017) Quantitative body fluid proteomics in medicine – a focus on minimal invasiveness. J Proteome 153:30–43
Proctor GB, Carpenter GH (2014) Salivary secretion: mechanism and neural regulation. Monogr Oral Sci 24:14–29
Lee YH, Wong DT (2009) Saliva: an emerging biofluid for early detection of diseases. Am J Dent 22:241–248
Greabu M, Battino M, Mohora M, Totan A, Didilescu A, Spinu T, Totan C, Miricescu D, Radulescu R (2009) Saliva--a diagnostic window to the body, both in health and in disease. J Med Life 2:124–132
Kaczor-Urbanowicz KE, Martin Carreras-Presas C, Aro K, Tu M, Garcia-Godoy F, Wong DT (2017) Saliva diagnostics – current views and directions. Exp Biol Med (Maywood) 242:459–472
Pedersen AML, Belstrøm D (2019) The role of natural salivary defences in maintaining a healthy oral microbiota. J Dent 80:S3–S12
Li X, Liu Y, Yang X, Li C, Song Z (2022) The oral microbiota: community composition, influencing factors, pathogenesis, and interventions. Front Microbiol 13:895537
Carpenter GH (2020) Salivary factors that maintain the normal oral commensal microflora. J Dent Res 99:644–649
Jasim H, Olausson P, Hedenberg-Magnusson B, Ernberg M, Ghafouri B (2016) The proteomic profile of whole and glandular saliva in healthy pain-free subjects. Sci Rep 6:39073
Zhang CZ, Cheng XQ, Li JY, Zhang P, Yi P, Xu X, Zhou XD (2016) Saliva in the diagnosis of diseases. Int J Oral Sci 8:133–137
Proctor GB (2016) The physiology of salivary secretion. Periodontol 2000 70:11–25
Serag A, Shakkour Z, Halboup AM, Kobeissy F, Farag MA (2021) Sweat metabolome and proteome: recent trends in analytical advances and potential biological functions. J Proteome 246:104310
Trindade F, Barros AS, Silva J, Vlahou A, Falcão-Pires I, Guedes S, Vitorino C, Ferreira R, Leite-Moreira A, Amado F, Vitorino R (2021) Mining the biomarker potential of the urine peptidome: from amino acids properties to proteases. Int J Mol Sci 22:5940
Khurshid Z, Warsi I, Moin SF, Slowey PD, Latif M, Zohaib S, Zafar MS (2021) Biochemical analysis of oral fluids for disease detection. Adv Clin Chem 100:205–253
Lee PY, Osman J, Low TY, Jamal R (2019) Plasma/serum proteomics: depletion strategies for reducing high-abundance proteins for biomarker discovery. Bioanalysis 11:1799–1812
Peffers MJ, Smagul A, Anderson JR (2019) Proteomic analysis of synovial fluid: current and potential uses to improve clinical outcomes. Expert Rev Proteomics 16:287–302
Seino Y, Nakamura T, Kawarabayashi T, Hirohata M, Narita S, Wakasaya Y, Kaito K, Ueda T, Harigaya Y, Shoji M (2019) Cerebrospinal fluid and plasma biomarkers in neurodegenerative diseases. J Alzheimers Dis 68:395–404
Shokry E, Filho NRA (2017) Insights into cerumen and application in diagnostics: past, present and future prospective. Biochem Med (Zagreb) 27(3):030503
Azkargorta M, Soria J, Acera A, Iloro I, Elortza F (2017) Human tear proteomics and peptidomics in ophthalmology: toward the translation of proteomic biomarkers into clinical practice. J Proteome 150:359–367
Murphy S, Zweyer M, Mundegar RR, Swandulla D, Ohlendieck K (2018) Proteomic serum biomarkers for neuromuscular diseases. Expert Rev Proteomics 15:277–291
Torok Z, Peto T, Csosz E, Tukacs E, Molnar AM, Berta A, Tozser J, Hajdu A, Nagy V, Domokos B, Csutak A (2015) Combined methods for diabetic retinopathy screening, using retina photographs and tear fluid proteomics biomarkers. J Diabetes Res 2015:623619
Zhao M, Yang Y, Guo Z, Shao C, Sun H, Zhang Y, Sun Y, Liu Y, Song Y, Zhang L, Li Q, Liu J, Li M, Gao Y, Sun W (2018) A comparative proteomics analysis of five body fluids: plasma, urine, cerebrospinal fluid, amniotic fluid, and saliva. Proteomics Clin Appl 12(6):e1800008
Ilea A, Andrei V, Feurdean CN, Băbţan AM, Petrescu NB, Câmpian RS, Boşca AB, Ciui B, Tertiş M, Săndulescu R, Cristea C (2019) Saliva, a magic biofluid available for multilevel assessment and a mirror of general health-a systematic review. Biosensors (Basel) 9:27
Castagnola M, Scarano E, Passali GC, Messana I, Cabras T, Iavarone F, Di Cintio G, Fiorita A, De Corso E, Paludetti G (2017) Salivary biomarkers and proteomics: future diagnostic and clinical utilities. Acta Otorhinolaryngol Ital 37:94–101
Wilhelm M, Schlegl J, Hahne H, Gholami AM, Lieberenz M, Savitski MM, Ziegler E, Butzmann L, Gessulat S, Marx H, Mathieson T, Lemeer S, Schnatbaum K, Reimer U, Wenschuh H, Mollenhauer M, Slotta-Huspenina J, Boese JH, Bantscheff M, Gerstmair A, Faerber F, Kuster B (2014) Mass-spectrometry-based draft of the human proteome. Nature 509:582–587
Kim MS, Pinto SM, Getnet D, Nirujogi RS, Manda SS, Chaerkady R, Madugundu AK, Kelkar DS, Isserlin R, Jain S, Thomas JK, Muthusamy B, Leal-Rojas P, Kumar P, Sahasrabuddhe NA, Balakrishnan L, Advani J, George B, Renuse S, Selvan LD, Patil AH, Nanjappa V, Radhakrishnan A, Prasad S, Subbannayya T, Raju R, Kumar M, Sreenivasamurthy SK, Marimuthu A, Sathe GJ, Chavan S, Datta KK, Subbannayya Y, Sahu A, Yelamanchi SD, Jayaram S, Rajagopalan P, Sharma J, Murthy KR, Syed N, Goel R, Khan AA, Ahmad S, Dey G, Mudgal K, Chatterjee A, Huang TC, Zhong J, Wu X, Shaw PG, Freed D, Zahari MS, Mukherjee KK, Shankar S, Mahadevan A, Lam H, Mitchell CJ, Shankar SK, Satishchandra P, Schroeder JT, Sirdeshmukh R, Maitra A, Leach SD, Drake CG, Halushka MK, Prasad TS, Hruban RH, Kerr CL, Bader GD, Iacobuzio-Donahue CA, Gowda H, Pandey A (2014) A draft map of the human proteome. Nature 509:575–581
Paik YK, Omenn GS, Hancock WS, Lane L, Overall CM (2017) Advances in the chromosome-centric human proteome project: looking to the future. Expert Rev Proteomics 14:1059–1071
Jiang L, Wang M, Lin S, Jian R, Li X, Chan J, Dong G, Fang H, Robinson AE, GTEx Consortium, Snyder MP (2020) A quantitative proteome map of the human body. Cell 183:269–283.e19
Ghafouri B, Tagesson C, Lindahl M (2003) Mapping of proteins in human saliva using two-dimensional gel electrophoresis and peptide mass fingerprinting. Proteomics 3:1003–1015
Jehmlich N, Dinh KH, Gesell-Salazar M, Hammer E, Steil L, Dhople VM, Schurmann C, Holtfreter B, Kocher T, Völker U (2013) Quantitative analysis of the intra- and inter-subject variability of the whole salivary proteome. J Periodontal Res 48:392–403
Grassl N, Kulak NA, Pichler G, Geyer PE, Jung J, Schubert S, Sinitcyn P, Cox J, Mann M (2016) Ultra-deep and quantitative saliva proteome reveals dynamics of the oral microbiome. Genome Med 8(1):44
Amado FM, Vitorino RM, Domingues PM, Lobo MJ, Duarte JA (2005) Analysis of the human saliva proteome. Expert Rev Proteomics 2:521–539
Huang CM (2002) Comparative proteomic analysis of human whole saliva. Arch Oral Biol 49:951–962
Hu S, Xie Y, Ramachandran P, Ogorzalek Loo RR, Li Y, Loo JA, Wong DT (2005) Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry. Proteomics 5:1714–1728
Hu S, Jiang J, Wong DT (2010) Proteomic analysis of saliva: 2D gel electrophoresis, LC-MS/MS, and Western blotting. Methods Mol Biol 666:31–41
Minden JS, Dowd SR, Meyer HE, Stuhler K (2009) Difference gel electrophoresis. Electrophoresis 30:S156–S161
Arentz G, Weiland F, Oehler MK, Hoffmann P (2015) State of the art of 2D DIGE. Proteomics Clin Appl 9:277–288
Marouga R, David S, Hawkins E (2005) The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem 382:669–678
Ryu OH, Atkinson JC, Hoehn GT, Illei GG, Hart TC (2006) Identification of parotid salivary biomarkers in Sjogren’s syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology (Oxford) 45:1077–1086
Kohlgraf KG, Ackermann AR, Burnell KK, Srikantha RN, Joly SA, Bartlett JA, Gakhar L, Johnson GK, McCray PB Jr, Guthmiller JM, Brogden KA (2012) Quantitation of SPLUNC1 in saliva with an xMAP particle-based antibody capture and detection immunoassay. Arch Oral Biol 57:197–204
Rao AA, Mehta K, Gahoi N, Srivastava S (2019) Application of 2D-DIGE and iTRAQ workflows to analyze CSF in gliomas. Methods Mol Biol 2044:81–110
Sivagnanam A, Shyamsundar V, Kesavan P, Krishnamurthy A, Thangaraj SV, Venugopal DC, Kasirajan H, Ramani P, Sarma VR, Ramshankar V (2022) 2D-DIGE-based proteomic profiling with validations identifies vimentin as a secretory biomarker useful for early detection and poor prognosis in oral cancers. J Oncol 2022:4215097
Dupree EJ, Jayathirtha M, Yorkey H, Mihasan M, Petre BA, Darie CC (2020) A critical review of bottom-up proteomics: the good, the bad, and the future of this field. Proteomes 8:14
Duong VA, Park JM, Lee H (2020) Review of three-dimensional liquid chromatography platforms for bottom-up proteomics. Int J Mol Sci 21:1524
Révész Á, Hevér H, Steckel A, Schlosser G, Szabó D, Vékey K, Drahos L (2021) Collision energies: optimization strategies for bottom-up proteomics. Mass Spectrom Rev 2:e21763
Padula MP, Berry IJ, O Rourke MB, Raymond BB, Santos J, Djordjevic SP (2017) A comprehensive guide for performing sample preparation and top-down protein analysis. Proteomes 5:11
Dowling P, Zweyer M, Swandulla D, Ohlendieck K (2019) Characterization of contractile proteins from skeletal muscle using gel-based top-down proteomics. Proteomes 7:25
Cupp-Sutton KA, Wu S (2020) High-throughput quantitative top-down proteomics. Mol Omics 16:91–99
Alban A, David SO, Bjorkesten L, Andersson C, Sloge E, Lewis S, Currie I (2003) A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3:36–44
Blundon M, Ganesan V, Redler B, Van PT, Minden JS (2019) Two-dimensional difference gel electrophoresis. Methods Mol Biol 1855:229–247
Karp NA, Kreil DP, Lilley KS (2004) Determining a significant change in protein expression with DeCyder during a pair-wise comparison using two-dimensional difference gel electrophoresis. Proteomics 4:1421–1432
Karp NA, Lilley KS (2005) Maximising sensitivity for detecting changes in protein expression: experimental design using minimal CyDyes. Proteomics 5:3105–3115
Carberry S, Zweyer M, Swandulla D, Ohlendieck K (2013) Application of fluorescence two-dimensional difference in-gel electrophoresis as a proteomic biomarker discovery tool in muscular dystrophy research. Biology (Basel) 2:1438–1464
Tonge R, Shaw J, Middleton B, Rowlinson R, Rayner S, Young J, Pognan F, Hawkins E, Currie I, Davison M (2001) Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 1:377–396
Karn RC, Chung AG, Laukaitis CM (2013) Shared and unique proteins in human, mouse and rat saliva proteomes: footprints of functional adaptation. Proteomes 1:275–289
Murphy S, Zweyer M, Mundegar RR, Swandulla D, Ohlendieck K (2018) Dataset on the comparative proteomic profiling of mouse saliva and serum from wild type versus the dystrophic mdx-4cv mouse model of dystrophinopathy. Data Brief 21:1236–1245
Murphy S, Zweyer M, Mundegar RR, Swandulla D, Ohlendieck K (2018) Proteomic identification of elevated saliva kallikrein levels in the mdx-4cv mouse model of Duchenne muscular dystrophy. Biochem Biophys Rep 18:100541
Lorenzo-Pouso AI, Pérez-Sayáns M, Bravo SB, López-Jornet P, García-Vence M, Alonso-Sampedro M, Carballo J, García-García A (2018) Protein-based salivary profiles as novel biomarkers for oral diseases. Dis Markers 2018:6141845
Rudney JD, Staikov RK, Johnson JD (2009) Potential biomarkers of human salivary function: a modified proteomic approach. Arch Oral Biol 54:91–100
Shin MS, Kim YG, Shin YJ, Ko BJ, Kim S, Kim HD (2019) Deep sequencing salivary proteins for periodontitis using proteomics. Clin Oral Investig 23:3571–3580
Katsiougiannis S, Wong DT (2016) The proteomics of saliva in Sjögren’s syndrome. Rheum Dis Clin N Am 42:449–456
Hall SC, Hassis ME, Williams KE, Albertolle ME, Prakobphol A, Dykstra AB, Laurance M, Ona K, Niles RK, Prasad N, Gormley M, Shiboski C, Criswell LA, Witkowska HE, Fisher SJ (2017) Alterations in the salivary proteome and N-glycome of Sjögren’s syndrome patients. J Proteome Res 16:1693–1705
Ghallab NA (2018) Diagnostic potential and future directions of biomarkers in gingival crevicular fluid and saliva of periodontal diseases: review of the current evidence. Arch Oral Biol 87:115–124
Rao PV, Reddy AP, Lu X, Dasari S, Krishnaprasad A, Biggs E, Roberts CT, Nagalla SR (2009) Proteomic identification of salivary biomarkers of type-2 diabetes. J Proteome Res 8:239–245
Rahim MA, Rahim ZH, Ahmad WA, Hashim OH (2015) Can saliva proteins be used to predict the onset of acute myocardial infarction among high-risk patients? Int J Med Sci 12:329–335
Tong P, Yuan C, Sun X, Yue Q, Wang X, Zheng S (2019) Identification of salivary peptidomic biomarkers in chronic kidney disease patients undergoing haemodialysis. Clin Chim Acta 489:154–161
Gualtero DF, Suarez Castillo A (2016) Biomarkers in saliva for the detection of oral squamous cell carcinoma and their potential use for early diagnosis: a systematic review. Acta Odontol Scand 74:170–177
Winck FV, Prado Ribeiro AC, Ramos Domingues R, Ling LY, Riaño-Pachón DM, Rivera C, Brandão TB, Gouvea AF, Santos-Silva AR, Coletta RD, Paes Leme AF (2015) Insights into immune responses in oral cancer through proteomic analysis of saliva and salivary extracellular vesicles. Sci Rep 5:16305
Xiao H, Zhang Y, Kim Y, Kim S, Kim JJ, Kim KM, Yoshizawa J, Fan LY, Cao CX, Wong DT (2016) Differential proteomic analysis of human saliva using tandem mass tags quantification for gastric cancer detection. Sci Rep 6:22165
Sun Y, Huo C, Qiao Z, Shang Z, Uzzaman A, Liu S, Jiang X, Fan LY, Ji L, Guan X, Cao CX, Xiao H (2018) Comparative proteomic analysis of exosomes and microvesicles in human saliva for lung cancer. J Proteome Res 17:1101–1107
Khurshid Z, Zafar MS, Khan RS, Najeeb S, Slowey PD, Rehman IU (2018) Role of salivary biomarkers in oral cancer detection. Adv Clin Chem 86:23–70
Patel A, Patel S, Patel P, Tanavde V (2022) Saliva based liquid biopsies in head and neck cancer: how far are we from the clinic? Front Oncol 12:828434
Htike TT, Mishra S, Kumar S, Padmanabhan P, Gulyás B (2019) Peripheral biomarkers for early detection of Alzheimer’s and Parkinson’s diseases. Mol Neurobiol 56:2256–2277
Manconi B, Liori B, Cabras T, Vincenzoni F, Iavarone F, Lorefice L, Cocco E, Castagnola M, Messana I, Olianas A (2018) Top-down proteomic profiling of human saliva in multiple sclerosis patients. J Proteome 187:212–222
Korecka M, Shaw LM (2021) Mass spectrometry-based methods for robust measurement of Alzheimer’s disease biomarkers in biological fluids. J Neurochem 159:211–233
Campanati A, Martina E, Diotallevi F, Radi G, Marani A, Sartini D, Emanuelli M, Kontochristopoulos G, Rigopoulos D, Gregoriou S, Offidani A (2021) Saliva proteomics as fluid signature of inflammatory and immune-mediated skin diseases. Int J Mol Sci 22:7018
Jasim H, Ernberg M, Carlsson A, Gerdle B, Ghafouri B (2020) Protein signature in saliva of temporomandibular disorders myalgia. Int J Mol Sci 21:2569
Khurshid Z, Zohaib S, Najeeb S, Zafar MS, Slowey PD, Almas K (2016) Human saliva collection devices for proteomics: an update. Int J Mol Sci 17:E846
de Almeida PDV, Grégio AM, Machado MA, de Lima AA, Azevedo LR (2008) Saliva composition and functions: a comprehensive review. J Contemp Dent Pract 9:72–80
Yoshizawa JM, Schafer CA, Schafer JJ, Farrell JJ, Paster BJ, Wong DT (2013) Salivary biomarkers: toward future clinical and diagnostic utilities. Clin Microbiol Rev 26:781–791
Giannobile WV, Beikler T, Kinney JS, Ramseier CA, Morelli T, Wong DT (2009) Saliva as a diagnostic tool for periodontal disease: current state and future directions. Periodontol 2000 50:52–64
Yu D, Li Y, Wang M, Gu J, Xu W, Cai H, Fang X, Zhang X (2022) Exosomes as a new frontier of cancer liquid biopsy. Mol Cancer 21:56
Nonaka T, Wong DTW (2017) Saliva-exosomics in cancer: molecular characterization of cancer-derived exosomes in saliva. Enzyme 42:125–151
Kok VC, Yu CC (2020) Cancer-derived exosomes: their role in cancer biology and biomarker development. Int J Nanomedicine 15:8019–8036
Trevisan França de Lima L, Müller Bark J, Rasheduzzaman M, Weeramange CE, Punyadeera C (2022) Isolation and characterization of salivary exosomes for cancer biomarker discovery. Methods Mol Biol 2504:101–112
Lau CS, Wong DT (2012) Breast cancer exosome-like microvesicles and salivary gland cells interplay alters salivary gland cell-derived exosome-like microvesicles in vitro. PLoS One 7:e33037
Mi H, Ebert D, Muruganujan A, Mills C, Albou LP, Mushayamaha T, Thomas PD (2021) PANTHER version 16: a revised family classification, tree-based classification tool, enhancer regions and extensive API. Nucleic Acids Res 49(D1):D394–D403
Shah S (2018) Salivaomics: the current scenario. J Oral Maxillofac Pathol 22:375–381
Tasoulas J, Patsouris E, Giaginis C, Theocharis S (2016) Salivaomics for oral diseases biomarkers detection. Expert Rev Mol Diagn 16(3):285–295
Aro K, Kaczor-Urbanowicz K, Carreras-Presas CM (2019) Salivaomics in oral cancer. Curr Opin Otolaryngol Head Neck Surg 27:91–97
Kaczor-Urbanowicz KE, Martín Carreras-Presas C, Kaczor T, Tu M, Wei F, Garcia-Godoy F, Wong DT (2017) Emerging technologies for salivaomics in cancer detection. J Cell Mol Med 21:640–647
Chundru VNS, Nirmal RM, Srikanth B, Bojji M, Midhun N, Lakshmi BJ (2021) Salivaomics for oral cancer detection: an insight. J Pharm Bioallied Sci 13(Suppl 1):S52–S56
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249
Dowling P, Wormald R, Meleady P, Henry M, Curran A, Clynes M (2008) Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis. J Proteome 71:168–175
González-Arriagada WA, Ramos LM, Silva AA, Vargas PA, Coletta RD, Bingle L, Lopes MA (2015) Salivary BPIFA1 (SPLUNC1) and BPIFA2 (SPLUNC2 A) are modified by head and neck cancer radiotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol 119:48–58
Zhang L, Xiao H, Karlan S, Zhou H, Gross J, Elashoff D, Akin D, Yan X, Chia D, Karlan B, Wong DT (2010) Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer. PLoS One 5:e15573
Xiao H, Zhang L, Zhou H, Lee JM, Garon EB, Wong DT (2012) Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry. Mol Cell Proteomics 11:M111.012112
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
O’Sullivan, E.M., Dowling, P., Swandulla, D., Ohlendieck, K. (2023). Proteomic Identification of Saliva Proteins as Noninvasive Diagnostic Biomarkers. In: Ohlendieck, K. (eds) Difference Gel Electrophoresis. Methods in Molecular Biology, vol 2596. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2831-7_12
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2831-7_12
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2830-0
Online ISBN: 978-1-0716-2831-7
eBook Packages: Springer Protocols